Prosecution Insights
Last updated: April 19, 2026

Scribe Therapeutics Inc.

6 pending office actions

Portfolio Summary

6
Total Pending OAs
0
Final Rejections
6
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18039858 ENGINEERED CLASS 2 TYPE V CRISPR SYSTEMS ZARA, JANE J 1637 Non-Final OA Jun 01, 2023
18255182 COMPOSITIONS AND METHODS FOR THE TARGETING OF PTBP1 VIJAYARAGHAVAN, JAGAMYA NMN 1633 Non-Final OA May 31, 2023
18168426 COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1 BATES, KEENAN ALEXANDER 1631 Non-Final OA Feb 13, 2023
17932798 COMPOSITIONS AND METHODS FOR THE TARGETING OF C9orf72 MCLEOD, AFRICA MHAIRIE 1635 Non-Final OA Sep 16, 2022
17641426 COMPOSITIONS AND METHODS FOR THE TARGETING OF SOD1 RYAN, DOUGLAS CHARLES 1635 Non-Final OA Mar 08, 2022
17542219 ENGINEERED CASX SYSTEMS KONOPKA, CATHERINE ANNE 1635 Non-Final OA Dec 03, 2021

Managing Scribe Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month